ProQR Therapeutics NV (PRQR)
1.96
-0.05
(-2.49%)
USD |
NASDAQ |
Apr 25, 16:00
1.96
0.00 (0.00%)
Pre-Market: 20:00
ProQR Therapeutics Total Liabilities (Quarterly): 106.66M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 106.66M |
| September 30, 2023 | 101.29M |
| June 30, 2023 | 104.86M |
| March 31, 2023 | 108.29M |
| December 31, 2022 | 112.22M |
| September 30, 2022 | 56.21M |
| June 30, 2022 | 96.18M |
| March 31, 2022 | 100.47M |
| December 31, 2021 | 109.09M |
| September 30, 2021 | 78.07M |
| June 30, 2021 | 53.33M |
| March 31, 2021 | 49.74M |
| December 31, 2020 | 51.88M |
| September 30, 2020 | 49.43M |
| June 30, 2020 | 15.67M |
| March 31, 2020 | 24.58M |
| December 31, 2019 | 26.55M |
| September 30, 2019 | 23.68M |
| June 30, 2019 | 22.76M |
| March 31, 2019 | 23.37M |
| Date | Value |
|---|---|
| December 31, 2018 | 20.07M |
| September 30, 2018 | 19.28M |
| June 30, 2018 | 17.12M |
| March 31, 2018 | 15.80M |
| December 31, 2017 | 16.53M |
| September 30, 2017 | 15.14M |
| June 30, 2017 | 13.27M |
| March 31, 2017 | 13.24M |
| December 31, 2016 | 13.12M |
| September 30, 2016 | 12.77M |
| June 30, 2016 | 14.46M |
| March 31, 2016 | 12.69M |
| December 31, 2015 | 11.27M |
| September 30, 2015 | 10.29M |
| June 30, 2015 | 10.54M |
| March 31, 2015 | 8.291M |
| December 31, 2014 | 7.105M |
| September 30, 2014 | 6.885M |
| June 30, 2014 | 6.929M |
| December 31, 2013 | 6.342M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.67M
Minimum
Jun 2020
112.22M
Maximum
Dec 2022
67.95M
Average
56.21M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| uniQure NV | 624.02M |
| Merus NV | 99.15M |
| argenx SE | 444.95M |
| Pharming Group | 244.07M |
| Pharvaris NV | 16.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 152.42M |
| Shareholders Equity (Quarterly) | 45.75M |
| Debt to Equity Ratio | 0.1037 |
| Current Ratio | 3.537 |
| Net Debt Paydown Yield | 0.22% |